Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma
High-dose chemotherapy (HDT) with autologous stem cell transplantation (ASCT) is the standard of care for eligible multiple myeloma (MM) patients with improved progression-free and overall survival. We reviewed the ambulatory care unit pathway for MM patients who underwent HDT/ASCT in a tertiary hos...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Wolters Kluwer Medknow Publications
2021-04-01
|
| Sraith: | Hematology/Oncology and Stem Cell Therapy |
| Ábhair: | |
| Rochtain ar líne: | https://journals.lww.com/10.1016/j.hemonc.2020.01.001 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|